|
|
|
|
|
51.
15769 Accesses
|
Interleukin-6: discovery of a pleiotropic cytokine
Tadamitsu Kishimoto Arthritis Research & Therapy 2006, 8(Suppl 2):S2 (28 July 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
52.
15766 Accesses
|
Relationship between physical activity and stiff or painful joints in mid-aged women and older women: a 3-year prospective study
Kristiann C Heesch, Yvette D Miller, Wendy J Brown Arthritis Research & Therapy 2007, 9:R34 (29 March 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central |
|
|
|
53.
15497 Accesses
|
Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics
Robert Terkeltaub, David A Bushinsky, Michael A Becker Arthritis Research & Therapy 2006, 8(Suppl 1):S4 (12 April 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
54.
15464 Accesses
|
Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice
David J Shealy, Paul H Wooley, Eva Emmell, Amy Volk, Amy Rosenberg, George Treacy, Carrie L Wagner, Lois Mayton, Don E Griswold, Xiao-yu R Song Arthritis Res 2002, 4:R7 (28 June 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
55.
15422 Accesses
|
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study
Steeve Tat, Jean-Pierre Pelletier, Josep Vergés, Daniel Lajeunesse, Eulàlia Montell, Hassan Fahmi, Martin Lavigne, Johanne Martel-Pelletier Arthritis Research & Therapy 2007, 9:R117 (9 November 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A combination of glucosamine sulphate and chondroitin sulphate markedly reduces the resorptive activity of subchondral bone osteoblasts, suggesting a positive effect on early bone structural changes in osteoarthritis.
|
|
|
56.
15320 Accesses
|
A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria
Stéphane Poitras, Jérôme Avouac, Michel Rossignol, Bernard Avouac, Christine Cedraschi, Margareta Nordin, Chantal Rousseaux, Sylvie Rozenberg, Bernard Savarieau, Philippe Thoumie, Jean-Pierre Valat, Éric Vignon, Pascal Hilliquin Arthritis Research & Therapy 2007, 9:R126 (6 December 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Guidelines for treating knee osteoarthritis were found to lack educational information and differ in treatments addressed when they were reviewed using the Appraisal of Guidelines Research and Evaluation (AGREE) criteria.
|
|
|
57.
15273 Accesses
|
Arthritis and Pain. Neurogenic origin of joint pain
Jason J McDougall Arthritis Research & Therapy 2006, 8:220 (10 November 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
58.
15203 Accesses
|
Negative regulation of cytokine signaling and immune responses by SOCS proteins
Akihiko Yoshimura, Hitomi Nishinakamura, Yumiko Matsumura, Toshikatsu Hanada Arthritis Research & Therapy 2005, 7:100-110 (30 March 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
59.
15071 Accesses
|
Macrophages in rheumatoid arthritis
Raimund W Kinne, Rolf Bräuer, Bruno Stuhlmüller, Ernesta Palombo-Kinne, Gerd-R Burmester Arthritis Res 2000, 2:189-202 (12 April 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
60.
15065 Accesses
|
Arthritis and pain. Psychosocial aspects in the management of arthritis pain
Catherine L Backman Arthritis Research & Therapy 2006, 8:221 (5 December 2006)
Abstract | Full text | PDF
| PubMed |
|
|
|
61.
15025 Accesses
|
Magnetic resonance imaging in psoriatic arthritis: a review of the literature
Fiona McQueen, Marissa Lassere, Mikkel Østergaard Arthritis Research & Therapy 2006, 8:207 (23 March 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
62.
15022 Accesses
|
Signaling for survival and apoptosis in the immune system
Tak W Mak, Wen-Chen Yeh Arthritis Res 2002, 4(Suppl 3):S243-S252 (9 May 2002)
Abstract | Full text | PDF
| PubMed
|
|
|
63.
14992 Accesses
|
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
R Andrew Moore, Sheena Derry, Geoffrey T Makinson, Henry J McQuay Arthritis Research & Therapy 2005, 7:R644-R665 (24 March 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
64.
14967 Accesses
|
Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?
Sampath Prahalad, David N Glass Arthritis Res 2002, 4(Suppl 3):303-310 (24 July 2002)
Abstract | Full text | PDF
|
|
|
65.
14861 Accesses
|
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
Fiona E McCann, Andrew C Palfreeman, Melanie Andrews, Dany P Perocheau, Julia J Inglis, Peter Schafer, Marc Feldmann, Richard O Williams, Fionula M Brennan Arthritis Research & Therapy 2010, 12:R107 (2 June 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
66.
14734 Accesses
|
The clinical relevance of autoantibodies in scleroderma
Khanh T Ho, John D Reveille Arthritis Res Ther 2003, 5:80-93 (12 February 2003)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
67.
14666 Accesses
|
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study
Tuulikki Sokka, Sergio Toloza, Maurizio Cutolo, Hannu Kautiainen, Heidi Makinen, Feride Gogus, Vlado Skakic, Humeira Badsha, Tõnu Peets, Asta Baranauskaite, Pál Géher, Ilona Újfalussy, Fotini N Skopouli, Maria Mavrommati, Rieke Alten, Christof Pohl, Jean Sibilia, Andrea Stancati, Fausto Salaffi, Wojciech Romanowski, Danuta Zarowny-Wierzbinska, Dan Henrohn, Barry Bresnihan, Patricia Minnock, Lene Knudsen, Johannes WG Jacobs, Jaime Calvo-Alen, Juris Lazovskis, Geraldo Pinheiro, Dmitry Karateev, Daina Andersone, Sylejman Rexhepi, Yusuf Yazici, Theodore Pincus, the QUEST-RA Group et al.
Arthritis Research & Therapy 2009, 11:R7 (14 January 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Rheumatoid arthritis was more severe in women in an analysis of more than 6,000 patients, although the effects of gender on standard disease activity measures may explain the difference.
|
|
|
68.
14665 Accesses
|
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Robert M Bennett, Ronald Friend, Kim D Jones, Rachel Ward, Bobby K Han, Rebecca L Ross Arthritis Research & Therapy 2009, 11:R120 (10 August 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
69.
14605 Accesses
|
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols
Eleni Douni, Petros P Sfikakis, Sylva Haralambous, Peter Fernandes, George Kollias Arthritis Res Ther 2004, 6:R65-R72 (7 November 2003)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
70.
14579 Accesses
|
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture — primary culture cells markedly differ from fourth-passage cells
Thomas Zimmermann, Elke Kunisch, Robert Pfeiffer, Astrid Hirth, Hans-Detlev Stahl, Ulrich Sack, Anke Laube, Eckehard Liesaus, Andreas Roth, Ernesta Palombo-Kinne, Frank Emmrich, Raimund W Kinne Arthritis Res 2001, 3:72-76 (21 November 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
71.
14571 Accesses
|
Matrix metalloproteinases in arthritic disease
Gillian Murphy, Vera Knäuper, Susan Atkinson, George Butler, William English, Mike Hutton, Jan Stracke, Ian Clark Arthritis Res 2002, 4(Suppl 3):S39-S49 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
72.
14554 Accesses
|
A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis
James N Pencharz, Elizabeth Grigoriadis, Gwenderlyn F Jansz, Claire Bombardier Arthritis Res 2002, 4:36-44 (16 October 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
73.
14358 Accesses
|
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, Rene Westhovens, Patrick Durez, Filip Van den Bosch, Eric M Veys, Herman Mielants, Luc De Clerck, Anne Peretz, Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser Arthritis Research & Therapy 2005, 7:R1063-R1071 (8 July 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
74.
14329 Accesses
|
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
Martinus AM van Boekel, Erik R Vossenaar, Frank HJ van den Hoogen, Walther J van Venrooij Arthritis Res 2002, 4:87-93 (6 November 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
75.
14281 Accesses
|
The paradigm of IL-6: from basic science to medicine
Tetsuji Naka, Norihiro Nishimoto, Tadamitsu Kishimoto Arthritis Res 2002, 4(Suppl 3):S233-S242 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
76.
14280 Accesses
|
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
Nathan J Zvaifler Arthritis Research & Therapy 2006, 8:210 (9 May 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
77.
14235 Accesses
|
Biology of RANK, RANKL, and osteoprotegerin
Brendan F Boyce, Lianping Xing Arthritis Research & Therapy 2007, 9(Suppl 1):S1 (29 June 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
78.
14208 Accesses
|
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1
Helena d'Elia, Lars-Åke Mattsson, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten Arthritis Res Ther 2003, 5:R202-R209 (1 May 2003)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
79.
14074 Accesses
|
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So, Thibaut De Smedt, Sylvie Revaz, Jürg Tschopp Arthritis Research & Therapy 2007, 9:R28 (12 March 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
In a pilot study on 10 patients with gouty arthritis, IL-1 blockade with anakinra gave rapid relief of inflammatory symptoms where standard treatments had failed or were not tolerated.
|
|
|
80.
14050 Accesses
|
Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia
Manuel Martinez-Lavin Arthritis Research & Therapy 2007, 9:216 (6 July 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
81.
14032 Accesses
|
Gout. Novel therapies for treatment of gout and hyperuricemia
Robert Terkeltaub Arthritis Research & Therapy 2009, 11:236 (23 July 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
82.
14000 Accesses
|
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
Raphaela Goldbach-Mansky, Jennifer Lee, Angela McCoy, Joseph Hoxworth, Cheryl Yarboro, Josef S Smolen, Günter Steiner, Antony Rosen, Cindy Zhang, Henri A Ménard, Zhi Jie Zhou, Timo Palosuo, Walther J Van Venrooij, Ronald L Wilder, John H Klippel, H Ralph Schumacher, Hani S El-Gabalawy Arthritis Res 2000, 2:236-243 (31 March 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
83.
13981 Accesses
|
Oxidation in rheumatoid arthritis
Carol A Hitchon, Hani S El-Gabalawy Arthritis Res Ther 2004, 6:265-278 (13 October 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
84.
13974 Accesses
|
Does a positive anti-CCP test identify a distinct arthritis entity?
Thomas Skogh Arthritis Research & Therapy 2005, 7:230-232 (16 September 2005)
Abstract | Full text | PDF
| PubMed
|
|
|
85.
13954 Accesses
|
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
Flavia V Castelino, John Varga Arthritis Research & Therapy 2010, 12:213 (23 August 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
86.
13705 Accesses
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A Becker, H Ralph Schumacher, Luis R Espinoza, Alvin F Wells, Patricia MacDonald, Eric Lloyd, Christopher Lademacher Arthritis Research & Therapy 2010, 12:R63 (6 April 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
87.
13651 Accesses
|
Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model
Jianyong Shou, Christopher M Bull, Li Li, Hui-Rong Qian, Tao Wei, Shuang Luo, Douglas Perkins, Patricia J Solenberg, Seng-Lai Tan, Xin-Yi Chen, Neal W Roehm, Jeffrey A Wolos, Jude E Onyia Arthritis Research & Therapy 2006, 8:R28 (10 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
88.
13627 Accesses
|
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
Juan J Gomez-Reino, Loreto Carmona, the BIOBADASER Group Arthritis Research & Therapy 2006, 8:R29 (6 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
89.
13610 Accesses
|
Perspectives for TNF-α-targeting therapies
Hanns-Martin Lorenz, Joachim R Kalden Arthritis Res 2002, 4(Suppl 3):S17-S24 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
90.
13371 Accesses
|
Angiogenesis in rheumatoid arthritis
Ewa M Paleolog Arthritis Res 2002, 4(Suppl 3):S81-S90 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
91.
13357 Accesses
|
The life cycle of chondrocytes in the developing skeleton
Lillian Shum, Glen Nuckolls Arthritis Res 2002, 4:94-106 (8 November 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
92.
13244 Accesses
|
The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis
Eric M Ruderman, Richard M Pope Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 (16 March 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
93.
13166 Accesses
|
Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen
Julia J Inglis, Gabriel Criado, Mino Medghalchi, Melanie Andrews, Ann Sandison, Marc Feldmann, Richard O Williams Arthritis Research & Therapy 2007, 9:R113 (29 October 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
C57BL/6 mice may be useful for testing new therapeutics, particularly those directed against T cells, and investigating the action of current therapies in rheumatoid arthritis.
|
|
|
94.
13067 Accesses
|
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
Kutty Nandakumar, Johan Bäcklund, Mikael Vestberg, Rikard Holmdahl Arthritis Res Ther 2004, 6:R544-R550 (23 September 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
95.
13011 Accesses
|
Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis
C Thomas G Appleton, David D McErlain, Vasek Pitelka, Neil Schwartz, Suzanne M Bernier, James L Henry, David W Holdsworth, Frank Beier Arthritis Research & Therapy 2007, 9:R13 (6 February 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
96.
13010 Accesses
|
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Merete Pedersen, Søren Jacobsen, Mette Klarlund, Bo V Pedersen, Allan Wiik, Jan Wohlfahrt, Morten Frisch Arthritis Research & Therapy 2006, 8:R133 (27 July 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
97.
13001 Accesses
|
Rheumatic Diseases in China
Qing Zeng, Ren Chen, John Darmawan, Zheng Xiao, Su Chen, Richard Wigley, Shun Le Chen, Nai Zhang Arthritis Research & Therapy 2008, 10:R17 (31 January 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A large population study found that the incidence of certain rheumatic diseases in China is becoming more like that of Western countries, but different joints are affected compared to Caucasian populations.
|
|
|
98.
12992 Accesses
|
Epstein–Barr virus and rheumatoid arthritis: is there a link?
Karen H Costenbader, Elizabeth W Karlson Arthritis Research & Therapy 2006, 8:204 (16 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
99.
12949 Accesses
|
Autoantibodies in rheumatoid arthritis and their clinical significance
Günter Steiner, Josef Smolen Arthritis Res 2002, 4(Suppl 2):S1-S5 (26 April 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
100.
12925 Accesses
|
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia Arthritis Research & Therapy 2009, 11:R95 (23 June 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.
|